ICD-10-CM Codes for Neurology

Total Page:16

File Type:pdf, Size:1020Kb

ICD-10-CM Codes for Neurology Diagnostic Services ICD-10-CM Codes for Neurology ICD-10 ICD-10 Diagnoses Diagnoses Code Code Other Specified Congenital Malformation Behavioral/Cognitive Syndromes Q87.89 Syndromes, Not Elsewhere Classified Amnestic Disorder Due To Known Physiological F04 Multiple Congenital Malformations, Not Condition Q89.7 Elsewhere Classified Unspecified Mental Disorder Due To Known F09 Physiological Condition Q89.8 Other Specified Congenital Malformations Attention-Deficit Hyperactivity Disorder, Q89.9 Congenital Malformation, Unspecified F90.9 Unspecified Type Q99.2 Fragile X Chromosome F91.9 Conduct Disorder, Unspecified R62.0 Delayed Milestone In Childhood Cerebral Degeneration Genetic Disorders Unspecified Dementia Without Behavioral F03.90 E70.0 Classical Phenylketonuria Disturbance E70.1 Other Hyperphenylalaninemias G30.9 Alzheimer's Disease, Unspecified E72.04 Cystinosis G31.01 Pick's Disease E75.02 Tay-Sachs Disease G31.09 Other Frontotemporal Dementia E75.249 Niemann-Pick Disease, Unspecified G93.7 Reye's Syndrome E75.29 Other Sphingolipidosis R41.0 Disorientation, Unspecified E76.29 Other Mucopolysaccharidoses Cerebral Lobe Dysfunction E76.3 Mucopolysaccharidosis, Unspecified R41.3 Other Amnesia E83.01 Wilson's Disease R47.01 Aphasia Headache Disorders R48.1 Agnosia Migraine Without Aura, Not Intractable, With G43.001 R48.2 Apraxia Status Migrainosus Cerebrovascular Diseases Migraine Without Aura, Not Intractable, Without G43.009 G45.9 Transient Cerebral Ischemic Attack, Unspecified Status Migrainosus Migraine Without Aura, Intractable, With Status I63.9 Cerebral Infarction, Unspecified G43.011 Migrainosus Cranial Nerve Disorders Migraine Without Aura, Intractable, Without G52.9 Cranial Nerve Disorder, Unspecified G43.019 Status Migrainosus Developmental Delay Migraine With Aura, Not Intractable, With Status G43.101 E72.00 Disorders Of Amino-Acid Transport, Unspecified Migrainosus E72.01 Cystinuria Migraine With Aura, Not Intractable, Without G43.109 E72.09 Other Disorders Of Amino-Acid Transport Status Migrainosus Migraine With Aura, Intractable, With Status F70 Mild Intellectual Disabilities G43.111 Migrainosus F71 Moderate Intellectual Disabilities Migraine With Aura, Intractable, Without Status G43.119 F72 Severe Intellectual Disabilities Migrainosus F73 Profound Intellectual Disabilities Hemiplegic Migraine, Not Intractable, With Status G43.401 F79 Unspecified Intellectual Disabilities Migrainosus Hemiplegic Migraine, Not Intractable, Without F84.0 Autistic Disorder G43.409 Status Migrainosus F84.3 Other Childhood Disintegrative Disorder Hemiplegic Migraine, Intractable, With Status G43.411 F84.5 Asperger's Syndrome Migrainosus F84.8 Other Pervasive Developmental Disorders ICD-10-CM Codes for Neurology ICD-10 ICD-10 Diagnoses Diagnoses Code Code Hemiplegic Migraine, Intractable, Without Status Periodic Headache Syndromes In Child Or Adult, G43.419 G43.C1 Migrainosus Intractable Persistent Migraine Aura Without Cerebral G43.D0 Abdominal Migraine, Not Intractable G43.501 Infarction, Not Intractable, With Status G43.D1 Abdominal Migraine, Intractable Migrainosus Cluster Headache Syndrome, Unspecified, Not Persistent Migraine Aura Without Cerebral G44.009 Intractable G43.509 Infarction, Not Intractable, Without Status Migrainosus G44.1 Vascular Headache, Not Elsewhere Classified Persistent Migraine Aura Without Cerebral Tension-Type Headache, Unspecified, Not G43.511 G44.209 Infarction, Intractable, With Status Migrainosus Intractable Persistent Migraine Aura Without Cerebral G93.2 Benign Intracranial Hypertension G43.519 Infarction, Intractable, Without Status R47.02 Dysphasia Migrainosus R49.9 Unspecified Voice And Resonance Disorder Persistent Migraine Aura With Cerebral Infarction, G43.601 Not Intractable, With Status Migrainosus R51 Headache Persistent Migraine Aura With Cerebral Infarction, Infections G43.609 Not Intractable, Without Status Migrainosus G03.9 Meningitis, Unspecified Persistent Migraine Aura With Cerebral Infarction, G43.611 G04.90 Encephalitis And Encephalomyelitis, Unspecified Intractable, With Status Migrainosus G04.91 Myelitis, Unspecified Persistent Migraine Aura With Cerebral Infarction, G43.619 Intractable, Without Status Migrainosus Intracranial And Spinal Tumors Chronic Migraine Without Aura, Not Intractable, C71.6 Malignant Neoplasm Of Cerebellum G43.701 With Status Migrainosus C71.9 Malignant Neoplasm Of Brain, Unspecified Chronic Migraine Without Aura, Not Intractable, G43.709 C72.0 Malignant Neoplasm Of Spinal Cord Without Status Migrainosus C75.1 Malignant Neoplasm Of Pituitary Gland Chronic Migraine Without Aura, Intractable, With G43.711 Status Migrainosus D32.9 Benign Neoplasm Of Meninges, Unspecified Chronic Migraine Without Aura, Intractable, D49.6 Neoplasm Of Unspecified Behavior Of Brain G43.719 Without Status Migrainosus Q85.00 Neurofibromatosis, Unspecified Other Migraine, Not Intractable, Without Status G43.809 Motor Neuron Diseases Migrainosus G12.21 Amyotrophic Lateral Sclerosis Menstrual Migraine, Not Intractable, With Status G43.821 Migrainosus G12.29 Other Motor Neuron Disease Menstrual Migraine, Not Intractable, Without Movement And Cerebellar Disorders G43.829 Status Migrainosus F95.2 Tourette's Disorder Menstrual Migraine, Intractable, With Status F95.9 Tic Disorder, Unspecified G43.831 Migrainosus G10 Huntington's Disease Menstrual Migraine, Intractable, Without Status G43.839 G20 Parkinson's Disease Migrainosus G21.9 Secondary Parkinsonism, Unspecified Migraine, Unspecified, Not Intractable, Without G43.909 Progressive Supranuclear Ophthalmoplegia Status Migrainosus G23.1 [Steele-Richardson-Olszewski] G43.A0 Cyclical Vomiting, Not Intractable G24.02 Drug Induced Acute Dystonia G43.A1 Cyclical Vomiting, Intractable G24.8 Other Dystonia G43.B0 Ophthalmoplegic Migraine, Not Intractable G25.0 Essential Tremor G43.B1 Ophthalmoplegic Migraine, Intractable G25.1 Drug-Induced Tremor ICD-10 ICD-10 Diagnoses Diagnoses Code Code G25.2 Other Specified Forms Of Tremor G60.8 Other Hereditary And Idiopathic Neuropathies G25.3 Myoclonus Hereditary And Idiopathic Neuropathy, G60.9 G25.5 Other Chorea Unspecified G61.0 Guillain-Barre Syndrome R25.1 Tremor, Unspecified G70.00 Myasthenia Gravis Without (Acute) Exacerbation R25.2 Cramp And Spasm G70.01 Myasthenia Gravis With (Acute) Exacerbation R27.0 Ataxia Seizure Disorders Muscular Dystrophies And Other Myopathies Localization-Related (Focal) (Partial) G71.0 Muscular Dystrophy Symptomatic Epilepsy And Epileptic Syndromes G40.101 G71.11 Myotonic Muscular Dystrophy With Simple Partial Seizures, Not Intractable, With G71.12 Myotonia Congenita Status Epilepticus G71.14 Drug Induced Myotonia Localization-Related (Focal) (Partial) Symptomatic Epilepsy And Epileptic Syndromes G40.109 G71.2 Congenital Myopathies With Simple Partial Seizures, Not Intractable, G72.2 Myopathy Due To Other Toxic Agents Without Status Epilepticus G72.3 Periodic Paralysis Localization-Related (Focal) (Partial) Symptomatic Epilepsy And Epileptic Syndromes G40.111 G72.41 Inclusion Body Myositis [IBM] With Simple Partial Seizures, Intractable, With G72.9 Myopathy, Unspecified Status Epilepticus G73.7 Myopathy In Diseases Classified Elsewhere Localization-Related (Focal) (Partial) Symptomatic Epilepsy And Epileptic Syndromes G40.119 Other Neurological Disorders With Simple Partial Seizures, Intractable, Without G0.61 Intraspinal Abscess And Granuloma Status Epilepticus G11.1 Early-Onset Cerebellar Ataxia Localization-Related (Focal) (Partial) Symptomatic Epilepsy And Epileptic Syndromes G11.4 Hereditary Spastic Paraplegia G40.201 With Complex Partial Seizures, Not Intractable, G35 Multiple Sclerosis With Status Epilepticus G36.0 Neuromyelitis Optica [Devic] Localization-Related (Focal) (Partial) Symptomatic Epilepsy And Epileptic Syndromes G80.9 Cerebral Palsy, Unspecified G40.209 With Complex Partial Seizures, Not Intractable, Hemiplegia, Unspecified Affecting Unspecified G81.90 Without Status Epilepticus Side Localization-Related (Focal) (Partial) Acute Infarction Of Spinal Cord (Embolic) Symptomatic Epilepsy And Epileptic Syndromes G95.11 G40.211 (Nonembolic) With Complex Partial Seizures, Intractable, With G95.20 Unspecified Cord Compression Status Epilepticus G95.9 Disease Of Spinal Cord, Unspecified Localization-Related (Focal) (Partial) Symptomatic Epilepsy And Epileptic Syndromes G40.219 Q05.9 Spina Bifida, Unspecified With Complex Partial Seizures, Intractable, Peripheral Nervous System Disorders Without Status Epilepticus Generalized Idiopathic Epilepsy And Epileptic G12.9 Spinal Muscular Atrophy, Unspecified G40.311 Syndromes, Intractable, With Status Epilepticus G50.0 Trigeminal Neuralgia Generalized Idiopathic Epilepsy And Epileptic G51.0 Bell's Palsy G40.319 Syndromes, Intractable, Without Status G51.8 Other Disorders Of Facial Nerve Epilepticus G60.0 Hereditary Motor And Sensory Neuropathy Other Generalized Epilepsy And Epileptic G40.409 Syndromes, Not Intractable, Without Status G60.1 Refsum's Disease Epilepticus ICD-10 ICD-10 Diagnoses Diagnoses Code Code Other Generalized Epilepsy And Epileptic R56.01 Complex Febrile Convulsions G40.411 Syndromes, Intractable, With Status Epilepticus R56.1 Post Traumatic Seizures Other Generalized Epilepsy And Epileptic Sleep Disorders G40.419 Syndromes, Intractable, Without Status Epilepticus G25.81 Restless Legs Syndrome Lennox-Gastaut Syndrome, Not Intractable, With G47.00 Insomnia, Unspecified G40.811 Status Epilepticus Circadian Rhythm Sleep Disorder, Unspecified G47.20 Lennox-Gastaut Syndrome, Not Intractable,
Recommended publications
  • Cluster Headache: a Review MARILYN J
    • Cluster headache: A review MARILYN J. CONNORS, DO ID Cluster headache is a debilitat­ consists of episodes of excruciating facial pain that ing neuronal headache with secondary vas­ is generally unilateraP and often accompanied by cular changes and is often accompanied by ipsilateral parasympathetic phenomena including other characteristic signs and symptoms, such nasal congestion, rhinorrhea, conjunctival injec­ as unilateral rhinorrhea, lacrimation, and con­ tion, and lacrimation. Patients may also experi­ junctival injection. It primarily affects men, ence complete or partial Horner's syndrome (that and in many cases, patients have distinguishing is, unilateral miosis with normal direct light response facial, body, and psychologic features. Sever­ and mild ipsilateral ptosis, facial flushing, and al factors may precipitate cluster headaches, hyperhidrosis).4-6 These autonomic disturbances including histamine, nitroglycerin, alcohol, sometimes precede or occur early in the headache, transition from rapid eye movement (REM) adding credence to the theory that this constella­ to non-REM sleep, circadian periodicity, envi­ tion of symptoms is an integral part of an attack and ronmental alterations, and change in the level not a secondary consequence. Some investigators of physical, emotional, or mental activity. The consider cluster headache to exemplify a tempo­ pathophysiologic features have not been com­ rary and local imbalance between sympathetic and pletely elucidated, but the realms of neuro­ parasympathetic systems via the central nervous biology, intracranial hemodynamics, endocrinol­ system (CNS).! ogy, and immunology are included. Therapy The nomenclature of this form of headache in is prophylactic or abortive (or both). Treat­ the literature is extensive and descriptive, includ­ ment, possibly with combination regimens, ing such terminology as histamine cephalgia, ery­ should be tailored to the needs of the indi­ thromelalgia of the head, red migraine, atypical vidual patient.
    [Show full text]
  • Headache: General Considerations CQ I-1
    I Headache: General Considerations CQ I-1 How is headache classified and diagnosed? Recommendation Headache should be classified and diagnosed according to the International Classification of Headache Disorders 3rd edition (beta version). Grade A Background and Objective In 2004, the International Headache Society (IHS) revised the first edition of the IHS guideline for the first time in 15 years, incorporating the latest advances in research, evidence and criticisms. The resulting document, International Classification of Headache Disorders 2nd Edition (ICHD-2) was published in Cephalalgia.1) In the same year, the ICHD-2 was translated into Japanese and published.2) From 2004, headache should be classified and diagnosed in accordance with the ICHD-2. The first recorded classification of headache was by Aretaeus (a physician born in 81 BC) of Cappadacia in the present day Turkey, who classified headaches into cephalalgia, cephalea, and heterocrania.3)-5) Heterocrania was described as “half head” headache, which is equivalent to migraine in the present day classification. The first consensus-orientated headache classification in history was the classification by the Ad Hoc Committee on Classification of Headache of the American Neurological Association (Ad Hoc classification) published in 1962.6) In this classification, headache was classified into 15 types, but no diagnostic criteria were included. In 1988, the Headache Classification Committee of the International Headache Society chaired by Olesen proposed the first international classification of headache disorders (IHS Classification,st 1 edition, 1988).7) The IHS Classificationst 1 edition first classified headache into 13 items, and further subdivided into 165 headache types. For each subtype, operational criteria were described.
    [Show full text]
  • The Migraine-Epilepsy Syndrome
    medigraphic Artemisaen línea Arch Neurocien (Mex) Vol 11, No. 4: 282-287, 2006 The Migraine- Epilepsy Syndrome Arch Neurocien (Mex) Vol. 11, No. 4: 282-287, 2006 Artículo de revisión ©INNN, 2006 de caso The migraine-epilepsy syndrome Enrique Otero Siliceo†, Fernando Zermeño EL SINDROME MIGRAÑA-EPILEPSIA represent a neural exitation. Since that the glutamate has in important rol in both patologys depending of the part of the brain more affected the symptoms might RESUMEN vary from visual to abdominal phemomena. La migraña y la epilepsia tienen varios puntos en común Key words: migraine epilepsy, EEG abnormalities, sintomática clínica y genéticamente lo que ha sido glutamate, diagnosis. postulado por más de cien años. El fenómeno referido como migraña-epilepsia sugiere que exista una he first steps of a practical, approach by patofisiología común. El síndrome de migraña o physicians in recognizing and treating neuro- epilepsia tiene fenómenos comunes de dolor adominal T logic diseases are to recognithat there are jaqueca anormalidades del EE y respuesta a droga various overlaps between migraine and epilepsy. antiepilépticas. En ocasiones el paciente puede tener Epileptic seizures and classic migraine episodes may un ataque migrañoso o una convulsión o en otras occur in the same patient. Migraine and epilepsy share ambas. La comorbilidad puede explicarse por estados several genetic, clinical, evolutive and neurophysio- de hiperrexcitabilidad neural. Alteraciones electroen- logic features. A relationship between epilepsy and cefalográficas son comunes en estos estados. En migraine has been postulated for over a hundred years apariencia el glutamato tiene un papel importante tanto and the syndrome of Migraine-Epilepsy illustrates this en la migraña como en la epilepsia.
    [Show full text]
  • Migraine: Current Concepts and Emerging Therapies
    Vascular Pharmacology 43 (2005) 176 – 187 www.elsevier.com/locate/vph Migraine: Current concepts and emerging therapies D.K. Arulmozhi a,b,*, A. Veeranjaneyulu a, S.L. Bodhankar b aNew Chemical Entity Research, Lupin Research Park, Village Nande, Taluk Mulshi, Pune 411 042, Maharashtra, India bDepartment of Pharmacology, Bharati Vidyapeeth, Poona College of Pharmacy, Pune 411 038, Maharashtra, India Received 23 April 2005; received in revised form 17 June 2005; accepted 11 July 2005 Abstract Migraine is a recurrent incapacitating neurovascular disorder characterized by attacks of debilitating pain associated with photophobia, phonophobia, nausea and vomiting. Migraine affects a substantial fraction of world population and is a major cause of disability in the work place. Though the pathophysiology of migraine is still unclear three major theories proposed with regard to the mechanisms of migraine are vascular (due to cerebral vasodilatation), neurological (abnormal neurological firing which causes the spreading depression and migraine) and neurogenic dural inflammation (release of inflammatory neuropeptides). The modern understanding of the pathogenesis of migraine is based on the concept that it is a neurovascular disorder. The drugs used in the treatment of migraine either abolish the acute migraine headache or aim its prevention. The last decade has witnessed the advent of Sumatriptan and the Ftriptan_ class of 5-HT1B/1D receptor agonists which have well established efficacy in treating migraine. Currently prophylactic treatments for migraine include calcium channel blockers, 5-HT2 receptor antagonists, beta adrenoceptor blockers and g-amino butyric acid (GABA) agonists. Unfortunately, many of these treatments are non specific and not always effective. Despite such progress, in view of the complexity of the etiology of migraine, it still remains undiagnosed and available therapies are underused.
    [Show full text]
  • Migraine: Spectrum of Symptoms and Diagnosis
    KEY POINT: MIGRAINE: SPECTRUM A Most patients develop migraine in the first 3 OF SYMPTOMS decades of life, some in the AND DIAGNOSIS fourth and even the fifth decade. William B. Young, Stephen D. Silberstein ABSTRACT The migraine attack can be divided into four phases. Premonitory phenomena occur hours to days before headache onset and consist of psychological, neuro- logical, or general symptoms. The migraine aura is comprised of focal neurological phenomena that precede or accompany an attack. Visual and sensory auras are the most common. The migraine headache is typically unilateral, throbbing, and aggravated by routine physical activity. Cutaneous allodynia develops during un- treated migraine in 60% to 75% of cases. Migraine attacks can be accompanied by other associated symptoms, including nausea and vomiting, gastroparesis, di- arrhea, photophobia, phonophobia, osmophobia, lightheadedness and vertigo, and constitutional, mood, and mental changes. Differential diagnoses include cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoenphalopathy (CADASIL), pseudomigraine with lymphocytic pleocytosis, ophthalmoplegic mi- graine, Tolosa-Hunt syndrome, mitochondrial disorders, encephalitis, ornithine transcarbamylase deficiency, and benign idiopathic thunderclap headache. Migraine is a common episodic head- (Headache Classification Subcommittee, ache disorder with a 1-year prevalence 2004): of approximately 18% in women, 6% inmen,and4%inchildren.Attacks Recurrent attacks of headache, consist of various combinations of widely varied in intensity, fre- headache and neurological, gastrointes- quency, and duration. The attacks tinal, and autonomic symptoms. Most are commonly unilateral in onset; patients develop migraine in the first are usually associated with an- 67 3 decades of life, some in the fourth orexia and sometimes with nausea and even the fifth decade.
    [Show full text]
  • Vascular Surgery for Chronic Migraine
    RESEARCH ARTICLE Vascular surgery for chronic migraine Elliot Shevel Background: The superficial branches of the external carotid artery have been shown to The Headache Clinic, Suite 243, Private Bag be the origin of headache pain in some individuals. Surgical ligation of the temporal X2600, Houghton 2041, artery was first described by Al Zahrawi. Since then, excellent results have been achieved South Africa surgically in those patients in whom the superficial vessels have been positively identified Tel.: +27 114 840 933; Fax: +27 114 824 167; as the source of the headache pain. Aim: To determine the improvement in quality of life E-mail: drshevel@ in patients suffering from chronic daily headache (CDH) following cauterization of headclin.com superficial scalp vessels. Patients & methods: In total, 65 patients with CDH, in whom the superficial scalp vessels were positively identified as the source of pain, underwent surgical cauterization of the relevant vessels. Results: The quality of life of CDH sufferers in whom the pain was shown to originate in the superficial scalp vessels was significantly improved following surgical cauterization of the relevant vessels. Conclusion: Surgical cauterization of superficial scalp vessels can be a valuable treatment modality in selected patients with CDH. The extracranial branches of the external carotid revised criteria [31], and in whom there was a pos- artery are an important source of pain in some itive diagnosis of extracranial arterial pain, were patients with primary headaches [1–16]. In these included in the study. The subjects were patients, surgical cauterization of the relevant recruited from patients attending The Headache arteries provides permanent pain relief [17–26].
    [Show full text]
  • Clinical Algorithms
    BRITISH MEDICAL JOURNAL VOLUME 288 28 APRIL 1984 1281 Br Med J (Clin Res Ed): first published as 10.1136/bmj.288.6426.1281 on 28 April 1984. Downloaded from Clinical Algorithms Headache MICHAEL JAMIESON Headache, although a near universal experience, is a relatively (8) Headache due to overt cranial inflammation: uncommon reason for consultation in general practice. The consul- A Intracranial, tation rate for migraine, for example, is said to be 12 per 1000 B Extracranial (arteritis, cellulitis). consultations, and it is estimated that the average general practi- tioner will see 28 patients on account of headache yearly.' (9) Headache due to disease of ocular structures. Most headache is of the migrainous or tension type. Fry estimates (10) Headache due to disease of aural structures. that less than 1% of headaches presenting to a general practitioner reflect "major intracranial disease."2 Despite its predominantly (11) Headache due to disease of nasal and sinusal structures. benign nature, headache may, however, be the presenting feature of (12) Headache due to disease of dental structures. potentially serious conditions such as cerebral tumour, meningitis, giant cell arteritis, and glaucoma. Cervical spondylosis, chronic (13) Headache due to disease ofother cranial and neck structures. sinusitis, and refractory errors probably cause headache less often than is commonly supposed. (14) Cranial neuritides (trauma, new growth, inflammation). (15) Cranial neuralgias. Classification A useful classification is that of the National Institute of Neuro- Diagnosis logical Disease and Blindness 1962.3 This is summarised below. History-Try to discover why the patient is presenting now. In (1) Vascular headache of migraine type: many cases, particularly of acute onset headache, the reason will be A Classic migraine, clear.
    [Show full text]
  • Ischemic Stroke and Spontaneous Intracerebral Hematoma 887
    P1: KWW/KKL P2: KWW/HCN QC: KWW/FLX T1: KWW GRBT050-108 Olesen- 2057G GRBT050-Olesen-v6.cls August 17, 2005 1:41 ••HEADACHE ATTRIBUTED TO VASCULAR DISORDER ••Chapter 108 ◗ Ischemic Stroke and Spontaneous IntracerebralHematoma Panayiotis Mitsias and Troels Staehelin Jensen HEADACHE IN ISCHEMIC STROKE AND headache is an underemphasized symptom of ischemic SPONTANEOUS INTRACEREBRAL stroke, because it is usually overshadowed by other more HEMATOMA dramatic clinical manifestations, such as aphasia, hemi- plegia, hemianopsia, or neglect. Definitions Thomas Willis (1664) first recognized the relationship between headache and cerebrovascular disease in a patient International Headache Society (IHS) codes and diag- with asymptomatic carotid artery (CA) occlusion who ex- noses (23): perienced severe headache ipsilateral to the patent CA (63). 6.1.1 Headache attributed to ischemic stroke (cerebral in- Extreme dilation in the patent CA circulation, secondary to farction) collateral blood flow, was the postulated cause of headache A. Any acute headache fulfilling criterion C. (63). Three centuries later, Fisher reported the first com- B. Neurological signs and/or neuroimaging evidence of a prehensive study of headaches associated with ischemic recent ischemic stroke. and hemorrhagic cerebrovascular disease (18). Several au- C. Headache develops simultaneously with or in very thors subsequently provided detailed, but often conflicting, close temporal relation to signs or other evidence of data on the frequency, features, pathogenesis, and prog- ischemic stroke. nostic value of headache in acute cerebrovascular disease (6,14,16,17,21,27,30,32,36,40,42,45,51,52,60). 6.1.2 Headache attributed to transient ischemic attack (TIA) A. Any acute headache fulfilling criteria C and D.
    [Show full text]
  • A Review on Migraine
    Acta Scientific Pharmaceutical Sciences (ISSN: 2581-5423) Volume 3 Issue 1 January 2019 Review Article A Review on Migraine Poojitha Mamindla1*, Sharanya Mogilicherla1, Deepthi Enumula1, Om Prakash Prasad2 and Shyam Sunder Anchuri1 1Department of Pharm-D, Balaji Institute of Pharmaceutical Sciences, Laknepally, Narsampet, Warangal, Telangana, India 2Sri Sri Neurocentre, Hanamkonda, Warangal, Telangana, India *Corresponding Author: Poojitha Mamindla, Department of Pharm-D, Balaji Institute of Pharmaceutical Sciences, Laknepally, Narsampet, Warangal, Telangana, India. Received: November 02, 2018; Published: December 06, 2018 Abstract Headache disorders, characterized by recurrent headache, are among the most common disorders of the nervous system. Mi- graine, the second most common cause of headache and indeed neurologic cause of disability in the world and attacks lasting 4-72 hours, of a pulsating quality, moderate or severe intensity aggravated by routine physical activity and associated with nausea, vomit- ing, photophobia or phonophobia. Migraine has multiple phases: premonitory, aura, headache, postdrome, and interictal. The pri- mary cause of a migraine attack is unknown but probably lies within the central nervous system. Migraine can occur due to various triggering factors and can be managed with both pharmacological and non-pharmacological treatment. Migraine attacks are treated therapy, Complementary Treatments, yoga therapy etc. with nonsteroidal anti-inflammatory drugs (NSAIDS), or triptans. Non-pharmacological treatment includes cognitive behavioural Keywords: Migraine; NSAIDS; Therapy Introduction Migraine is a common chronic headache disorder which is char- acterized by the recurrent attacks which lasts from 4-72 hours, Headache disorders, this are characterized by the recurrent with a pulsating quality. Migraine is the commonest cause of head- episodes of headache and are the most common nervous system ache and its intensity includes as mild, moderate and severe, it is disorders.
    [Show full text]
  • “Vascular” Headache / 281 Lesion
    CHAPTER 51 THREE PATIENTS WITH “VASCULAR”HEADACHE LOUIS R. CAPLAN,MD Case History I •How can migraine be separated from intracranial bleeding? Since her early teens, a 28-year-old woman has had severe •How can intracerebral hemorrhage (ICH) be separated headaches nearly monthly. About half were preceded by from subarachnoid hemorrhage (SAH)? spots and jagged lines that slowly traveled across her vision. •How should the patient be evaluated? The visual display varied and could begin on either side of •How should she be treated? vision, and usually lasted about 20 minutes. Headaches followed and were pounding and severe, and were usually Case I Discussion followed by nausea. Headaches were common in her fam- ily. An aunt had died after a severe headache and the fam- The main differential diagnosis is between migraine and an ily was told that she had a “brain bleed.” acute intracranial process. Although the patient had severe While exercising in her home, after struggling to lift a headache, she had no symptoms or signs that indicate particularly heavy weight, she very suddenly developed a brain dysfunction. The right ptosis and dilated nonreactive severe generalized headache, more on the right side of the pupil suggest involvement of her right third cranial nerve. head. Her knees buckled and she felt dazed. She began to Does she have ophthalmoplegic migraine or a disorder vomit. She called out to her husband who was having that involves the meninges as well as the IIIrd nerve? The breakfast. He found her restless and a bit confused. He major relevant disorders that involve the meninges are brought her to the local emergency room.
    [Show full text]
  • Sturge-Weber Syndrome: a Review
    Review Article Sturge-Weber Syndrome: A Review Kristin A. Thomas-Sohl, BA*, Dale F. Vaslow, MD†, and Bernard L. Maria, MD, MBA‡ Sturge-Weber syndrome is a rare disorder that occurs Clinical Presentation and Diagnosis with a frequency of approximately 1 per 50,000. The disease is characterized by an intracranial vascular A child with Sturge-Weber syndrome typically presents anomaly, leptomeningeal angiomatosis, most often in- at birth with a facial cutaneous vascular malformation, a volving the occipital and posterior parietal lobes. Fa- port-wine nevus, usually affecting the upper face ipsilat- cial cutaneous vascular malformations, seizures, and eral to the angiomatosis. However, it is important to glaucoma are among the most common symptoms and observe that most children with a facial cutaneous vascular signs. Stasis results in ischemia underlying the lepto- malformation do not have SWS. When the cutaneous meningeal angiomatosis, leading to calcification and malformation is unilateral or bilateral and includes the laminar cortical necrosis. The clinical course is highly ophthalmic division of the trigeminal nerve, the likelihood variable and some children experience intractable sei- of SWS increases. The overall risk of SWS associated with zures, mental retardation, and recurrent strokelike any kind of facial cutaneous vascular malformation is episodes. In this review, we describe the syndrome’s approximately 8%. Children with the involvement of the characteristic features, clinical course, and optimal eyelids are at elevated risk for eye and brain disease [2]. management. © 2004 by Elsevier Inc. All rights Rarely, some children with SWS lack a facial cutaneous reserved. vascular malformation but have the neurologic or ophthal- mic components.
    [Show full text]
  • OBSERVATIONS on 500 CASES of MIGRAINE and ALLIED VASCULAR HEADACHE by GEORGE SELBY and JAMES W
    J. Neurol. Neurosurg. PsYchiat., 1960, 23, 23. OBSERVATIONS ON 500 CASES OF MIGRAINE AND ALLIED VASCULAR HEADACHE BY GEORGE SELBY and JAMES W. LANCE Fr-ottn the Northcott Neurological Centre, SYdneY, Auistralia Headache is probably the most common com- Aetiological Factors plaint referred to the neurologist for investigation. Sex Incidence. Our series comprises 300 females Approximately 12 % of all patients seen at the and 200 males. This female preponderance of 60% Northcott Neurological Centre during the past six is slightly lower than the figure quoted by Kinniet years were found to suffer from vascular headaches. Wilson (1940) who summarized 13 published series At this Centre facilities for investigation are avail- with a total of 3.278 cases and found that 716% able without involving the patient in additional were female. expense so that clinical observations are supported in most cases by electroencephalographic and radio- Age of Onset.-The age at which the first attack logical examinations. occurred in 496 cases is shown in Fig. 1. The figure The exact definition of the migraine syndrome is of 21 %" beginning under the age of 10 years is a difficult and debatable and not all the patients in this little less than Gowers' estimate of one-third and series would fall within the narrow concept of a that of Balyeat and Rinkel (1931), who found an paroxysmal disturbance of cerebral function asso- onset in the first decade in 30% of their 202 cases. ciated with unilateral headache and vomiting. The Krayenbuhl and Heyck (1955), on the other hand, term "migraine" might reasonably be restricted to state that only 12°' of their 170 cases started in the a disorder consisting of two separate phases, intra- first decade.
    [Show full text]